Priority setting during the COVID-19 pandemic: going beyond vaccines

Iestyn Williams, Beverley Essue, Elysee Nouvet, Lars Sandman, Donya Razavi, Mariam Noorulhuda, Susan Goold, Marion Danis, Godfrey Biemba, Julia Abelson, Lydia Kapiriri

Research output: Contribution to journalComment/debatepeer-review

115 Downloads (Pure)


Development of vaccines is a major breakthrough in the fight against the SARS-CoV-2 virus.

Much attention has been paid to how to prioritise between patient groups for vaccination and how to ensure equity, especially in low-income countries, but there are other important decisions that need to be made.

These decisions include: (a) choosing between the various vaccines that will become available, (b) continuing to invest in other aspects of the COVID-19 response and (c) balancing the COVID-19 response with the need to invest in other healthcare that has suffered during the pandemic.

Although these decisions are inherently difficult, principles of good priority setting can be helpful; these principles include: evidence-based and transparent decision-making, participation of stakeholders and a focus on the implementation of decisions.
Original languageEnglish
Article numbere004686
Number of pages4
JournalBMJ Global Health
Issue number1
Early online date18 Jan 2021
Publication statusPublished - Jan 2021


  • COVID-19 Vaccines/administration & dosage
  • COVID-19/epidemiology
  • Cost-Benefit Analysis
  • Decision Making
  • Health Priorities
  • Humans
  • Pandemics/prevention & control
  • SARS-CoV-2


Dive into the research topics of 'Priority setting during the COVID-19 pandemic: going beyond vaccines'. Together they form a unique fingerprint.

Cite this